Beijing Chunlizhengda Medical Instruments

SEHK:1858 Stock Report

Mkt Cap: HK$7.9b

We’ve recently updated our valuation analysis.

Beijing Chunlizhengda Medical Instruments Valuation

Is 1858 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 1858?

Other financial metrics that can be useful for relative valuation.

1858 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue4.6x
Enterprise Value/EBITDA15.8x
PEG Ration/a

Price to Earnings Ratio vs Peers

How does 1858's PE Ratio compare to its peers?

1858 PE Ratio vs Peers
The above table shows the PE ratio for 1858 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average42.5x
1302 LifeTech Scientific
36.9xn/aHK$12.3b
1789 AK Medical Holdings
76.8x42.8%HK$9.1b
6699 Angelalign Technology
45.2x32.8%HK$13.2b
1696 Sisram Medical
11x20.8%HK$3.1b
1858 Beijing Chunlizhengda Medical Instruments
13.1xn/aHK$7.9b

Price-To-Earnings vs Peers: 1858 is good value based on its Price-To-Earnings Ratio (13.1x) compared to the peer average (42.5x).


Price to Earnings Ratio vs Industry

How does 1858's PE Ratio compare vs other companies in the Asian Medical Equipment Industry?

Price-To-Earnings vs Industry: 1858 is good value based on its Price-To-Earnings Ratio (13.1x) compared to the Asian Medical Equipment industry average (19.4x)


Price to Earnings Ratio vs Fair Ratio

What is 1858's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

1858 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio13.1x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 1858's Price-To-Earnings Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of 1858 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 1858 (HK$12.18) is trading above our estimate of fair value (HK$3.15)

Significantly Below Fair Value: 1858 is trading above our estimate of fair value.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies